Since may 12th SP has been performing below 30 cents and shows no trend up. for all the big talk by management clearly no reflection on SP. next two quarter we will clearly see if the decisions that this management team are making the mark, if they are not would be happy to see change in top leadership. the company is run by pharma execs who have limited experience in device industry with tavr that has completely different set of dynamics to working with drugs. Lets see.
Since may 12th SP has been performing below 30 cents and shows...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |